Dr. Lucy Gilbert is a Professor in the Department of Obstetrics & Gynecology and the Department of Oncology at McGill University. She is the Director of Gynecologic Oncology at McGill University and McGill University Health Centre (MUHC), which is a designated level-IV unit that provides gynecological cancer care for the province of Quebec.

Dr Gilbert heads the Women’s Health Research Unit of the MUHC, which focuses on research that produces practical and immediate benefits for women with cancer. The Women’s Health Research Unit is active in collaborative multinational clinical trials investigating new precision therapies for gynecologic cancers.

However, Dr Gilbert’s main area of interest is the early detection of ovarian and uterine cancers while they are still curable. To this end, she has set up a network of satellite clinics called DOvEE (Diagnosing Ovarian and Endometrial Cancers Early) which provide open access and fast-track investigations to women over 45 with symptoms associated with gynecologic cancers.

She and her team have developed a new genetic pap-test called DOvEEgene for detecting these cancers very early before they even cause symptoms. Her team has completed the Phase I & II testing of the DOvEEgene test and is set to launch the Phase III.